Table 2 Replication and transmission of cold-adapted H9N2 virus in chickens.

From: Generation and protective efficacy of a cold-adapted attenuated avian H9N2 influenza vaccine

Virus

Group

Virus shedding in oropharynx on day a

Virus shedding in cloaca on day a

Virus replication in tracheas on day a

Virus replication in lungs on day a

2

4

2

4

2

3

5

7

2

3

5

7

SD/01/10-wt

Inoculation

6/6 (5.3 ± 0.6)

6/6 (4.9 ± 0.5)

6/6 (3.3 ± 0.7)

4/6 (2.2 ± 0.3)

6/6 (3.4 ± 0.4) b

6/6 (4.4 ± 0.4)

6/6 (3.6 ± 0.2)

1/6 (1.5)

6/6 (4.2 ± 0.4)

6/6 (5.3 ± 0.9)

6/6 (3.5 ± 0.3)

1/6 (1.8)

Contact

6/6 (4.8 ± 0.3)

6/6 (5.2 ± 0.4)

6/6 (3.7 ± 0.2)

2/6 (2.0 ± 0.4)

/

/

/

/

/

/

/

/

SD/01/10-ca

Inoculation

5/6 (1.3 ± 0.5)

0/6

0/6

0/6

6/6 (1.8 ± 0.4)

0/6

0/6

0/6

0/6

0/6

0/6

0/6

Contact

0/6

0/6

0/6

0/6

/

/

/

/

/

/

/

/

  1. a3-week-old SPF chickens were inoculated intranasally with 106 EID50 in 0.2 mL of SD/01/10-ca or SD/01/10-wt. At 24 h post inoculation, six naive in-contact chickens were added to each infected group. Six inoculated chickens in each group were killed on day 2, 3, 5, 7 post inoculation and their organs were collected. Oropharyngeal and cloacal swabs of directly infected chickens and in-contact chickens were collected on 2 and 4 days post inoculation. Collected organs and swabs were titrated in eggs.
  2. bNo. of chickens positive for virus/total no. of chickens tested (mean titers [log10 EID50/mL] ± standard errors).